Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Detection of Incidental Prostate Cancer or Urothelial Carcinoma Extension in Urinary Bladder Cancer Patients by Using Multiparametric MRI: A Retrospective Study Using Prostate Imaging Reporting and Data System Version 2.0

´ëÇÑ¿µ»óÀÇÇÐȸÁö 2020³â 81±Ç 3È£ p.610 ~ 619
À±»óÀº, °­º´Ã¶, Á¶ÇöÇý, ¹Ú»óÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
À±»óÀº ( Yoon Sang-Eun ) 
Ewha Womans University Mokdong Hospital Department of Radiology

°­º´Ã¶ ( Kang Byung-Chul ) 
Ewha Womans University Mokdong Hospital Department of Radiology
Á¶ÇöÇý ( Cho Hyun-Hae ) 
Ewha Womans University Mokdong Hospital Department of Radiology
¹Ú»óÈñ ( Park Sang-Hui ) 
Ewha Womans University College of Medicine Department of Pathology

Abstract


Purpose: The study aimed to investigate the role of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) in predicting incidental prostate cancer (PCa) or urothelial carcinoma (UCa) extension in urinary bladder (UB) cancer patients.

Materials and Methods: A total of 72 UB cancer patients who underwent radical cystoprostatectomy and 3 Tesla multiparametric MRI before surgery were enrolled. PI-RADS v2 ratings were assigned by two independent radiologists. All prostate specimens were examined by a single pathologist. We compared the multiparametric MRI findings rated using PI-RADS v2 with the pathologic data.

Results: Of the 72 UB cancer patients, 29 had incidental PCa (40.3%) and 20 showed UCa extension (27.8%), with an overlap for 3 patients. With a score of 4 as the cut-off value for predicting incidental PCa, the diagnostic accuracy was 65.3%, specificity was 90.7%, and positive predictive value (PPV) was 66.7%. The diagnostic accuracy for incidental UCa extension was 47.2%, specificity was 92.3%, and PPV was 83.3%.

Conclusion: Despite the low diagnostic accuracy, the PPV and specificity were relatively high. Therefore, PI-RADS v2 scores of 1, 2, or 3 may help exclude the probability of incidental PCa or UCa extension.

Å°¿öµå

Cystectomy; Magnetic Resonance Imaging; Prostate Cancer; Urinary Bladder Cancer

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS